Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product–receptor axis
Takanori Matsui(Fukui Prefectural University), Sho-ichi Yamagishi(Showa University)
Cited by 12
Related Papers
No related papers found
Powered by citation graph analysis